Spending, utilization, and price trends for anti-obesity medications in U.S. Medicaid programs: an empirical analysis from 1999 to 2023
BackgroundObesity poses a significant public health and economic challenge in the United States (U.S.), with rising prevalence, particularly among individuals enrolled in Medicaid—the nation’s public health insurance program for low-income populations. Anti-obesity medications (AOMs) have become int...
Saved in:
| Main Authors: | Abdulrahman A. Alsuhibani, Marwan A. Alrasheed, Ibrahim S. Alhomoud, Saud Alsahali, Ziyad S. Almalki, Jeff Jianfei Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1537181/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antifungal Agents’ Trends of Utilization, Spending, and Prices in the US Medicaid Programs: 2009–2023
by: Abdulrahman A. Alsuhibani, et al.
Published: (2025-05-01) -
Trends in carbapenem antibiotics utilization, costs, and market dynamics in Medicaid: a retrospective analysis from 1991 to 2023
by: Marwan A. Alrasheed, et al.
Published: (2025-08-01) -
Unveiling Medicaid fraud and abuse: the influence of price transparency and state political context
by: Ahreum Han, et al. -
Tobacco treatment billing and tobacco use disorder diagnosis in healthcare settings in the United States: an analysis of South Carolina medicaid claims
by: Kinsey Pebley, et al.
Published: (2025-06-01) -
Trends in cardiometabolic multimorbidity in non-elderly adult Medicaid enrollees, 2018–2022
by: Puneet Kaur Chehal, et al.
Published: (2025-06-01)